99 related articles for article (PubMed ID: 24192531)
1. Exploratory analysis of 1936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients.
Ten Brink MH; Swen JJ; Böhringer S; Wessels JA; van der Straaten T; Marijt EW; von dem Borne PA; Zwaveling J; Guchelaar HJ
Pharmacogenet Genomics; 2013 Dec; 23(12):675-83. PubMed ID: 24192531
[TBL] [Abstract][Full Text] [Related]
2. Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.
ten Brink MH; van Bavel T; Swen JJ; van der Straaten T; Bredius RG; Lankester AC; Zwaveling J; Guchelaar HJ
Pharmacogenomics; 2013 Nov; 14(14):1683-90. PubMed ID: 24192117
[TBL] [Abstract][Full Text] [Related]
3. Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Kim SD; Lee JH; Hur EH; Lee JH; Kim DY; Lim SN; Choi Y; Lim HS; Bae KS; Noh GJ; Yun SC; Han SB; Lee KH
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1222-30. PubMed ID: 21215809
[TBL] [Abstract][Full Text] [Related]
4. Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.
ten Brink MH; Wessels JA; den Hartigh J; van der Straaten T; von dem Borne PA; Guchelaar HJ; Zwaveling J
Bone Marrow Transplant; 2012 Feb; 47(2):190-5. PubMed ID: 21441958
[TBL] [Abstract][Full Text] [Related]
5. Linearity and stability of intravenous busulfan pharmacokinetics and the role of glutathione in busulfan elimination.
Almog S; Kurnik D; Shimoni A; Loebstein R; Hassoun E; Gopher A; Halkin H; Nagler A
Biol Blood Marrow Transplant; 2011 Jan; 17(1):117-23. PubMed ID: 20601034
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation.
Choi B; Kim MG; Han N; Kim T; Ji E; Park S; Kim IW; Oh JM
Pharmacogenomics; 2015; 16(14):1585-94. PubMed ID: 26419450
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
Zwaveling J; Press RR; Bredius RG; van Derstraaten TR; den Hartigh J; Bartelink IH; Boelens JJ; Guchelaar HJ
Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537
[TBL] [Abstract][Full Text] [Related]
8. Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning.
Bremer S; Fløisand Y; Brinch L; Gedde-Dahl T; Bergan S
Ther Drug Monit; 2015 Aug; 37(4):493-500. PubMed ID: 25565670
[TBL] [Abstract][Full Text] [Related]
9. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children.
Ansari M; Lauzon-Joset JF; Vachon MF; Duval M; Théoret Y; Champagne MA; Krajinovic M
Bone Marrow Transplant; 2010 Feb; 45(2):261-7. PubMed ID: 19584821
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.
Bredschneider M; Klein K; Mürdter TE; Marx C; Eichelbaum M; Nüssler AK; Neuhaus P; Zanger UM; Schwab M
Clin Pharmacol Ther; 2002 Jun; 71(6):479-87. PubMed ID: 12087351
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.
Ansari M; Rezgui MA; Théoret Y; Uppugunduri CR; Mezziani S; Vachon MF; Desjean C; Rousseau J; Labuda M; Przybyla C; Duval M; Champagne M; Peters C; Bittencourt H; Krajinovic M;
Bone Marrow Transplant; 2013 Jul; 48(7):939-46. PubMed ID: 23292236
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantation.
Paci A; Vassal G; Moshous D; Dalle JH; Bleyzac N; Neven B; Galambrun C; Kemmel V; Abdi ZD; Broutin S; Pétain A; Nguyen L
Ther Drug Monit; 2012 Apr; 34(2):198-208. PubMed ID: 22406655
[TBL] [Abstract][Full Text] [Related]
13. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation.
Elhasid R; Krivoy N; Rowe JM; Sprecher E; Adler L; Elkin H; Efrati E
Pediatr Blood Cancer; 2010 Dec; 55(6):1172-9. PubMed ID: 20672371
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Sun Y; Huang J; Hao C; Li Z; Liang W; Zhang W; Chen B; Yang W; Hu J
Cancer Chemother Pharmacol; 2020 Feb; 85(2):293-308. PubMed ID: 31834435
[TBL] [Abstract][Full Text] [Related]
15. Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients.
Ansari M; Huezo-Diaz P; Rezgui MA; Marktel S; Duval M; Bittencourt H; Cappelli B; Krajinovic M
Bone Marrow Transplant; 2016 Mar; 51(3):377-83. PubMed ID: 26691424
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
Nava T; Kassir N; Rezgui MA; Uppugunduri CRS; Huezo-Diaz Curtis P; Duval M; Théoret Y; Daudt LE; Litalien C; Ansari M; Krajinovic M; Bittencourt H
Br J Clin Pharmacol; 2018 Jul; 84(7):1494-1504. PubMed ID: 29469189
[TBL] [Abstract][Full Text] [Related]
17. Busulfan in hematopoietic stem cell transplant setting.
McCune JS; Holmberg LA
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):957-69. PubMed ID: 19611402
[TBL] [Abstract][Full Text] [Related]
18. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.
Kusama M; Kubota T; Matsukura Y; Matsuno K; Ogawa S; Kanda Y; Iga T
Clin Chim Acta; 2006 Jun; 368(1-2):93-8. PubMed ID: 16448639
[TBL] [Abstract][Full Text] [Related]
19. Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation.
Bonifazi F; Storci G; Bandini G; Marasco E; Dan E; Zani E; Albani F; Bertoni S; Bontadini A; De Carolis S; Sapienza MR; Rizzi S; Motta MR; Ferioli M; Garagnani P; Cavo M; Mantovani V; Bonafè M
Haematologica; 2014 Jan; 99(1):172-9. PubMed ID: 24056816
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.
Abbasi N; Vadnais B; Knutson JA; Blough DK; Kelly EJ; O'Donnell PV; Deeg HJ; Pawlikowski MA; Ho RJ; McCune JS
J Clin Pharmacol; 2011 Oct; 51(10):1429-38. PubMed ID: 21135089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
